TERLIVAZ TERLIPRESSIN FOR INJECTION Logo (USPTO, 05/04/2020)
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark TERLIVAZ TERLIPRESSIN FOR INJECTION was filed as Word and figurative mark on 05/04/2020 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 06/13/2023.
The current status of the mark is "REGISTERED".
#USPTO: 26.17.05 - Lines, horizontal, Horizontal line(s), band(s) or bar(s), Bars, horizontal, Bands, horizontal #USPTO: 26.17.09 - Lines, curved, Curved line(s), band(s) or bar(s), Bands, curved, Bars, curved #USPTO: 26.17.13 - Overlined words or letters, Underlined words or letters, Letters or words underlined and/or overlined by one or more strokes or lines
Trademark form | Word and figurative mark |
File reference | 7081079 |
Register number | 88900093 |
Application date | May 4, 2020 |
Entry date | June 13, 2023 |
Expiration date | June 13, 2033 |
ID: 13